Biolife Sciences (Biolife Sciences) EBITDA Margin % : 8.62% (As of May. 2008)

Biolife Sciences EBITDA Margin % Chart

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
EBITDA Margin %	Get a 7-Day Free Trial										9.17	3.03	-0.17	-2.43	8.62

Competitive Comparison of Biolife Sciences's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, Biolife Sciences's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biolife Sciences's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolife Sciences's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Biolife Sciences's EBITDA Margin % falls into.

Biolife Sciences EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Biolife Sciences's EBITDA Margin % for the fiscal year that ended in Nov. 2007 is calculated as

Biolife Sciences's EBITDA Margin % for the quarter that ended in May. 2008 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biolife Sciences  (OTCPK:BLFE) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Biolife Sciences EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description